Clinical Trial Update: Study of Nivolumab and Relatlimab in Patients With Microsatellite Stable (MSS) Advanced Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 study results of nivolumab plus relatlimab in patients with microsatellite-stable advanced colorectal cancer have been posted, marking a completed trial…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Adenocarcinoma
• Colorectal Cancer

Drugs mentioned

• Relatlimab (relatlimab)
• nivolumab (nivolumab)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Microsatellite Stable (MSS) Colorectal Adenocarcinomas, Colorectal Adenocarcinoma | Phase 2 | Status: COMPLETED | Results posted: 2025-01-28